Role of gain of 12p in germ cell tumour development

被引:109
作者
Looijenga, LHJ
Zafarana, G
Grygalewicz, B
Summersgill, B
Debiec-Rychter, M
Veltman, J
Schoenmakers, EFPM
Rodriguez, S
Jafer, O
Clark, J
Van Kessel, AG
Shipley, J
Van Gurp, RJHLM
Gillis, AJM
Oosterhuis, JW
机构
[1] Erasmus MC Daniel den Hoed Canc Ctr, Josephine Nefkens Inst, PatholLab Expt Pathooncol, NL-3000 DR Rotterdam, Netherlands
[2] Univ Leuven, Ctr Human Genet, Louvain, Belgium
[3] Maria Sklodowska Curie Mem Canc Ctr & Inst, Cytogenet Lab, Warsaw, Poland
[4] Inst Canc Res, Male Urol Canc Res Ctr, Sect Mol Carcinogenesis, Surrey, England
[5] Univ Med Ctr Nijmegen, Dept Human Genet, Nijmegen, Netherlands
[6] Inst Canc Res, Male Urol Canc Res Ctr, Sect Mol Carcinogenesis, Cell Transformat Team, Surrey, England
关键词
germ cell tumours; 12p; candidate gene(s); tumour progression; apoptosis; anoikis;
D O I
10.1034/j.1600-0463.2003.11101201.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Within the human testis, three entities of germ cell tumours are distinguished: the teratomas and yolk sac tumors of newborn and infants, the seminomas and nonseminomas of adolescents and young adults, referred to as testicular germ cell tumours (TGCT), and the spermatocytic seminomas. Characteristic chromosomal anomalies have been reported for each group, supporting their distinct pathogenesis. TGCT are the most common cancer in young adult men. The,initiating pathogenetic event of these turnours occurs during embryonal development, affecting a primordial germ cell or gonocyte. Despite this intra-uterine initiation, the tumour will only be clinically manifest after puberty, with carcinoma in situ (CIS) as the precursor. All invasive TGCT, both seminomas and nonseminomas, as well as CIS cells are aneuploid. The only consistent (structural) chromosomal abnormalities in invasive TGCT are gains of the short arm of chromosome 12, mostly due to isochromosome (i(12p)) formation. This suggests that an increase in copy number of a gene(s) on 12p is associated with the development of a clinically manifest TGCT Despite the numerous (positional) candidate gene approaches that have been undertaken thus far, identification of a causative gene(s) has been hampered by the fact that most 12p gains involve rather large genomic intervals, containing unmanageable numbers of candidate genes. Several years ago, we initiated a search for 12p candidate genes using TGCT with a restricted 12p-amplification, cytogenetically identified as 12p11.2-p12.1. This approach is mainly based on identification of candidate genes mapped within the shortest region of overlap of amplification (SROA). In this review, data will be presented, which support the model that gain of 12p-sequences is associated with suppression of apoptosis and Sertoli cell-independence of CIS cells. So far, DAD-R is one of the most likely candidate genes involved in this process, possibly via N-glycosylation. Preliminary results on high through-put DNA- and cDNA array analyses of 12p-sequences will be presented.
引用
收藏
页码:161 / 173
页数:13
相关论文
共 105 条
[1]   Germ cell survival through carbohydrate-mediated interaction with Sertoli cells [J].
Akama, TO ;
Nakagawa, H ;
Sugihara, K ;
Narisawa, S ;
Ohyama, C ;
Nishimura, SI ;
O'Brien, DA ;
Moremen, KW ;
Millán, JL ;
Fukuda, MN .
SCIENCE, 2002, 295 (5552) :124-127
[2]   Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene [J].
Albertson, DG ;
Ylstra, B ;
Segraves, R ;
Collins, C ;
Dairkee, SH ;
Kowbel, D ;
Kuo, WL ;
Gray, JW ;
Pinkel, D .
NATURE GENETICS, 2000, 25 (02) :144-146
[3]   The onset of germ cell migration in the mouse embryo [J].
Anderson, R ;
Copeland, TK ;
Schöler, H ;
Heasman, J ;
Wylie, C .
MECHANISMS OF DEVELOPMENT, 2000, 91 (1-2) :61-68
[4]   HUMAN EMBRYONAL CARCINOMA-CELLS AND THEIR DIFFERENTIATION IN CULTURE [J].
ANDREWS, PW ;
FENDERSON, B ;
HAKOMORI, SI .
INTERNATIONAL JOURNAL OF ANDROLOGY, 1987, 10 (01) :95-104
[5]  
Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO
[6]  
2-0
[7]  
ATKIN NB, 1982, LANCET, V2, P1349
[8]   I(12P) - SPECIFIC CHROMOSOMAL MARKER IN SEMINOMA AND MALIGNANT TERATOMA OF THE TESTIS [J].
ATKIN, NB ;
BAKER, MC .
CANCER GENETICS AND CYTOGENETICS, 1983, 10 (02) :199-204
[9]   Evolution by polyploidy in Amphibia:: new insights [J].
Beçak, ML ;
Beçak, W .
CYTOGENETICS AND CELL GENETICS, 1998, 80 (1-4) :28-33
[10]  
CHAGANTI RSK, 1990, J NATL CANCER I, V82, P1433, DOI 10.1093/jnci/82.17.1433-a